SCHEMBL734260

SCHEMBL734260

COc1ccc2[nH]c(C3CCC(Cc4ccccc4)(N(C)C)CC3)c(C)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
MAPKAPK2 P49137 5/20 0.44
HTR7 P34969 3/20 0.40
CHRM4 P08173 1/20 0.40
DRD2 P14416 1/20 0.40
HTR6 P50406 4/20 0.39
HTR1A P08908 2/20 0.39
HTR1D P28221 2/20 0.39
HTR5A P47898 2/20 0.39
SLC6A4 P31645 1/20 0.39
KDM4E B2RXH2 2/20 0.39
CFTR P13569 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
OPRM1 P35372 2/20 0.39
OGFRL1 Q5TC84 2/20 0.39
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL735113 0.88 S1PR1 (0.38) MEN1KMT2AMAPKAPK2KDM4EMAPT
SCHEMBL733701 0.85 OPRM1 (0.47) OPRM1OGFRL1ACHEOPRL1
SCHEMBL733702 0.85 OPRM1 (0.47) OPRM1OGFRL1ACHEOPRL1
SCHEMBL734388 0.85 HTR2A (0.42) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL733191 0.85 OPRM1 (0.49) MEN1KMT2ADRD2ALDH1A1MAPT
SCHEMBL734186 0.83 OPRM1 (0.43) MEN1KMT2AOPRM1OGFRL1
SCHEMBL734767 0.83 SLC6A4 (0.43) MEN1KMT2AHTR6HTR1ASLC6A4
SCHEMBL733588 0.82 MAPKAPK2 (0.41) MEN1KMT2AMAPKAPK2HTR7HTR6
SCHEMBL735676 0.82 OPRM1 (0.52) MEN1KMT2AMAPKAPK2KDM4EALDH1A1
SCHEMBL736437 0.75 KMT2A (0.46) MEN1KMT2AHTR7DRD2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
EP-2044016-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2009-04-08 EP disclosed
WO-2008009415-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1- AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 MEN1 2253/4885KMT2A 2453/4885MAPKAPK2 3000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.